文献速递肥胖与代谢综合征糖尿病

胆汁酸改变与肥胖者的胰岛素抵抗相关,但与NASH无关

Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

研究从2006至2014年招募肥胖患者,比较活检证实的NASH患者(n=32)与健康肝脏者(n=26),按BMI和胰岛素抵抗匹配。结果显示血浆胆汁酸浓度与肝脏病变无关,而初级胆汁酸与胰岛素抵抗强相关;NASH患者肝脏胆汁酸代谢、合成标志物及胆汁酸受体激活均无改变。

要点

  • 血浆胆汁酸浓度与肝脏病变无相关性,但初级胆汁酸与胰岛素抵抗强相关。
  • NASH患者肝脏胆汁酸代谢转录组分析未见改变,血浆7α-羟基-4-胆甾烯-3-酮未变。
  • NASH患者无肝脏胆汁酸蓄积或胆汁酸受体(FXR、PXR、VDR)激活迹象,肠道胆汁酸代谢与信号似无改变。

核心结论

  • 在肥胖患者中,胆汁酸改变与NASH相关的代谢表型(尤其是胰岛素抵抗)有关,但与肝脏坏死性炎症无关。

研究设计与样本

  • 研究招募2006至2014年就诊于Antwerp大学医院肥胖门诊(三级转诊机构)的患者。
  • 肥胖患者按体重指数和胰岛素抵抗稳态模型评估匹配,包括活检证实的NASH患者(n=32)和健康肝脏者(n=26)。

主要发现

  • 血浆胆汁酸浓度与任何肝脏病变均不相关,而初级胆汁酸与胰岛素抵抗强相关。
  • 转录组分析显示NASH患者肝脏胆汁酸代谢未改变,血浆7α-羟基-4-胆甾烯-3-酮在NASH中未变。
  • 未发现肝脏胆汁酸蓄积或胆汁酸受体——法尼醇X受体、孕烷X受体和维生素D受体——激活的迹象。
  • 血浆成纤维细胞生长因子19、次级与初级胆汁酸比值、游离与结合胆汁酸比值均相似,提示肠道胆汁酸代谢与信号未改变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Bile acids (BAs) are signaling molecules controlling energy homeostasis that can be both toxic and protective for the liver. BA alterations have been reported in obesity, insulin resistance (IR), and nonalcoholic steatohepatitis (NASH). However, whether BA alterations contribute to NASH independently of the metabolic status is unclear. OBJECTIVE: To assess BA alterations associated with NASH independently of body mass index and IR. DESIGN AND SETTING: Patients visiting the obesity clinic of the Antwerp University Hospital (a tertiary referral facility) were recruited from 2006 to 2014. PATIENTS: Obese patients with biopsy-proven NASH (n = 32) and healthy livers (n = 26) were matched on body mass index and homeostasis model assessment of IR. MAIN OUTCOME MEASURES: Transcriptomic analyses were performed on liver biopsies. Plasma concentrations of 21 BA species and 7α-hydroxy-4-cholesten-3-one, a marker of BA synthesis, were determined by liquid chromatography-tandem mass spectrometry. Plasma fibroblast growth factor 19 was measured by enzyme-linked immunosorbent assay. RESULTS: Plasma BA concentrations did not correlate with any hepatic lesions, whereas, as previously reported, primary BA strongly correlated with IR. Transcriptomic analyses showed unaltered hepatic BA metabolism in NASH patients. In line, plasma 7α-hydroxy-4-cholesten-3-one was unchanged in NASH. Moreover, no sign of hepatic BA accumulation or activation of BA receptors-farnesoid X, pregnane X, and vitamin D receptors-was found. Finally, plasma fibroblast growth factor 19, secondary-to-primary BA, and free-to-conjugated BA ratios were similar, suggesting unaltered intestinal BA metabolism and signaling. CONCLUSIONS: In obese patients, BA alterations are related to the metabolic phenotype associated with NASH, especially IR, but not liver necroinflammation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Legry V, Francque S, Haas JT, et al. Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects. J Clin Endocrinol Metab. 2017. PMID: 28938455. doi:10.1210/jc.2017-01397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。